SBIR-STTR Award

Novel System for Sensitive Detection of Botulinum Neurotoxins
Award last edited on: 11/5/14

Sponsored Program
SBIR
Awarding Agency
NIH : NIAID
Total Award Amount
$149,986
Award Phase
1
Solicitation Topic Code
-----

Principal Investigator
Alexey G Zdanovsky

Company Information

Alpha Universe LLC

1202 Ann Street
Madison, WI 53713
   (608) 661-0861
   ask@alphayou.com
   www.alphayou.com
Location: Single
Congr. District: 02
County: Dane

Phase I

Contract Number: 1R43AI112146-01
Start Date: 6/1/14    Completed: 12/31/14
Phase I year
2014
Phase I Amount
$149,986
The existence of terrorist organizations around the world, along with their ability to recruit expertise from physicians and scientists, poses an increasing threat of bioterrorist attack to society. In order to reduce the consequences of such an attack or even prevent it, new systems for detection of biothreat agents are necessary. Currently existing 'express' methods suffer from either being too expensive and complicated or lacking sensitivity. In contrast, we propose to develop a new system that will be inexpensive, simple to use, and highly sensitive. This system will be created by combining a novel signal amplification approach, developed in our lab, with advances in directed protein evolution. To prove the viability of our approach, during Phase I, we will develop the first components of this detection system targeted at the receptor- recognizing domain of Botulinum Neurotoxin Serotype A. In Phase II, this approach will be used to develop additional detectors for a universal Botulinum Neurotoxin detection system.

Thesaurus Terms:
Antigens;Area;Bacteriophage M13;Bacteriophages;Base;Binding (Molecular Function);Biothreat;Bontoxilysin;Capsid;Catalytic Domain;Cdr1 Gene;Cells;Complementarity Determining Regions;Detection;Detector;Development;Discrimination (Psychology);Dna Restriction Enzymes;Environment;Enzyme-Linked Immunosorbent Assay;Evolution;Genome;Goals;Immunoglobulins;Interest;Libraries;Llama;Location;Luciferases;Methods;Modification;Novel;Phase;Physicians;Polypeptide;Prevent;Procedures;Property;Proteins;Public Health Relevance;Randomized;Receptor;Recruitment Activity;Research;Research Design;Research Methodology;Research Study;Scaffold;Scientist;Screening;Serotyping;Signal Transduction;Site;Societies;Structure;Structure-Activity Relationship;System;Terminator Codon;Time;Vector;Work;

Phase II

Contract Number: ----------
Start Date: 00/00/00    Completed: 00/00/00
Phase II year
----
Phase II Amount
----